{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:15:46Z","timestamp":1775884546720,"version":"3.50.1"},"publisher-location":"Cham","reference-count":119,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319521732","type":"print"},{"value":"9783319521756","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/164_2016_72","type":"book-chapter","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T05:40:26Z","timestamp":1478583626000},"page":"153-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Leukotriene Receptor Antagonists and Antiallergy Drugs"],"prefix":"10.1007","author":[{"given":"Tsutomu","family":"Tamada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ichinose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,9]]},"reference":[{"issue":"9","key":"72_CR1","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1365-2222.2012.03982.x","volume":"42","author":"TM Laidlaw","year":"2012","unstructured":"Laidlaw TM, Boyce JA (2012) Cysteinyl leukotriene receptors, old and new; implications for asthma. Clin Exp Allergy 42(9):1313\u20131320","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"72_CR2","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","volume":"173","author":"Y Kanaoka","year":"2004","unstructured":"Kanaoka Y, Boyce AA (2004) Cysteinyl leukotrienes and their receptors: (Cellular distribution and function in immune and inflammatory responses. J Immunol 173(3):1503\u20131510","journal-title":"J Immunol"},{"issue":"4","key":"72_CR3","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4168\/aair.2014.6.4.288","volume":"6","author":"Y Kanaoka","year":"2014","unstructured":"Kanaoka Y, Boyce JA (2014) Cysteinyl leukotrienes and their receptors; emerging concepts. Allergy Asthma Immunol Res 6(4):288\u2013295","journal-title":"Allergy Asthma Immunol Res"},{"issue":"19","key":"72_CR4","doi-asserted-by":"crossref","first-page":"7708","DOI":"10.1073\/pnas.87.19.7708","volume":"87","author":"JD Clark","year":"1990","unstructured":"Clark JD, Milona N, Knopf JL (1990) Purification of a 110-kilodalton cytosolic phospholipase-A2 from the human monocytic cell-line U937. Proc Natl Acad Sci U S A 87(19):7708\u20137712","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"32","key":"72_CR5","doi-asserted-by":"crossref","first-page":"19818","DOI":"10.1016\/S0021-9258(17)45446-9","volume":"265","author":"GK Reid","year":"1990","unstructured":"Reid GK, Kargman S, Vickers PJ, Mancini JA, Leveille C, Ethier D et al (1990) Correlation between expression of 5-lipoxygenase-activating protein, 5-lipoxygenase, and cellular leukotriene synthesis. J Biol Chem 265(32):19818\u201319823","journal-title":"J Biol Chem"},{"issue":"16","key":"72_CR6","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1073\/pnas.91.16.7663","volume":"91","author":"BK Lam","year":"1994","unstructured":"Lam BK, Penrose JF, Freeman GJ, Austen KF (1994) Expression cloning of a cDNA for human leukotriene C4 synthase, an integral membrane protein conjugating reduced glutathione to leukotriene A4. Proc Natl Acad Sci U S A 91(16):7663\u20137667","journal-title":"Proc Natl Acad Sci U S A"},{"key":"72_CR7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.1994.tb12038.x","volume":"714","author":"J Maclouf","year":"1994","unstructured":"Maclouf J, Antoine C, Henson PM, Murphy RC (1994) Leukotriene C4 formation by transcellular biosynthesis. Ann N Y Acad Sci 714:143\u2013150, Epub 1994\/04\/18","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"72_CR8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1164\/ajrccm\/146.1.104","volume":"146","author":"JM Drazen","year":"1992","unstructured":"Drazen JM, Obrien J, Sparrow D, Weiss ST, Martins MA, Israel E et al (1992) Recovery of leukotriene-E4 from the urine of patients with airway-obstruction. Am Rev Respir Dis 146(1):104\u2013108","journal-title":"Am Rev Respir Dis"},{"issue":"5 Pt 1","key":"72_CR9","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","volume":"143","author":"PE Christie","year":"1991","unstructured":"Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP et al (1991) Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 143(5 Pt 1):1025\u20131029","journal-title":"Am Rev Respir Dis"},{"issue":"5 Pt 1","key":"72_CR10","first-page":"859","volume":"98","author":"MC Liu","year":"1996","unstructured":"Liu MC, Dube LM, Lancaster J (1996) Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. J Allergy Clin Immunol 98(5 Pt 1):859\u2013871","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"72_CR11","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jama.1996.03530360041036","volume":"275","author":"E Israel","year":"1996","unstructured":"Israel E, Cohn J, Dube L, Drazen JM (1996) Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma \u2013 a randomized controlled trial. JAMA 275(12):931\u2013936","journal-title":"JAMA"},{"issue":"10","key":"72_CR12","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","volume":"32","author":"MP Berges-Gimeno","year":"2002","unstructured":"Berges-Gimeno MP, Simon RA, Stevenson DD (2002) The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions. Clin Exp Allergy 32(10):1491\u20131496","journal-title":"Clin Exp Allergy"},{"issue":"4542","key":"72_CR13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1126\/science.7063880","volume":"216","author":"JW Weiss","year":"1982","unstructured":"Weiss JW, Drazen JM, Coles N, Mcfadden ER, Weller PF, Corey EJ et al (1982a) Bronchoconstrictor effects of leukotriene-C in humans. Science 216(4542):196\u2013198","journal-title":"Science"},{"issue":"8","key":"72_CR14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM198302243080807","volume":"308","author":"M Griffin","year":"1983","unstructured":"Griffin M, Weiss JW, Leitch AG, Mcfadden ER, Corey EJ, Austen KF et al (1983) Effects of leukotriene-D on the airways in asthma. N Engl J Med 308(8):436\u2013439","journal-title":"N Engl J Med"},{"issue":"15","key":"72_CR15","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1073\/pnas.81.15.4922","volume":"81","author":"TH Lee","year":"1984","unstructured":"Lee TH, Austen KF, Corey EJ, Drazen JM (1984) Leukotriene E4-induced airway hyperresponsiveness of guinea pig tracheal smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci U S A 81(15):4922\u20134925","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"72_CR16","first-page":"290","volume":"125","author":"JM Drazen","year":"1982","unstructured":"Drazen JM, Venugopalan CS, Austen KF, Brion F, Corey EJ (1982) Effects of leukotriene-E on pulmonary mechanics in the guinea-pig. Am Rev Respir Dis 125(3):290\u2013294","journal-title":"Am Rev Respir Dis"},{"issue":"20","key":"72_CR17","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1001\/jama.1983.03330440052033","volume":"249","author":"JW Weiss","year":"1983","unstructured":"Weiss JW, Drazen JM, Mcfadden ER, Weller P, Corey EJ, Lewis RA et al (1983) Airway constriction in normal humans produced by inhalation of leukotriene-D \u2013 potency, time course, and effect of aspirin therapy. JAMA 249(20):2814\u20132817","journal-title":"JAMA"},{"issue":"2","key":"72_CR18","first-page":"A571","volume":"30","author":"JW Weiss","year":"1982","unstructured":"Weiss JW, Drazen JM, Mcfadden ER, Lewis R, Weller P, Corey EJ et al (1982b) Comparative bronchoconstrictor effects of histamine and leukotriene-C and leukotriene-D (Ltc and Ltd) in normal human volunteers. Clin Res 30(2):A571","journal-title":"Clin Res"},{"issue":"2","key":"72_CR19","first-page":"333","volume":"135","author":"AB Davidson","year":"1987","unstructured":"Davidson AB, Lee TH, Scanlon PD, Solway J, Mcfadden ER, Ingram RH et al (1987) Bronchoconstrictor effects of leukotriene-E4 in normal and asthmatic subjects. Am Rev Respir Dis 135(2):333\u2013337","journal-title":"Am Rev Respir Dis"},{"issue":"10","key":"72_CR20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1183\/09031936.93.06101468","volume":"6","author":"PE Christie","year":"1993","unstructured":"Christie PE, Schmitz-Schumann M, Spur BW, Lee TH (1993) Airway responsiveness to leukotriene C4 (LTC4), leukotriene E4 (LTE4) and histamine in aspirin-sensitive asthmatic subjects. Eur Respir J 6(10):1468\u20131473","journal-title":"Eur Respir J"},{"issue":"8 Pt 1","key":"72_CR21","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1164\/ajrccm.164.8.2102033","volume":"164","author":"GM Gauvreau","year":"2001","unstructured":"Gauvreau GM, Parameswaran KN, Watson RM, O\u2019Byrne PM (2001) Inhaled leukotriene E(4), but not leukotriene D(4), increased airway inflammatory cells in subjects with atopic asthma. Am J Respir Crit Care Med 164(8 Pt 1):1495\u20131500","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"72_CR22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1164\/ajrccm\/146.6.1506","volume":"146","author":"PE Christie","year":"1992","unstructured":"Christie PE, Hawksworth R, Spur BW, Lee TH (1992) Effect of indomethacin on leukotriene4-induced histamine hyperresponsiveness in asthmatic subjects. Am Rev Respir Dis 146(6):1506\u20131510","journal-title":"Am Rev Respir Dis"},{"issue":"3","key":"72_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0167-4781(00)00271-2","volume":"1517","author":"J Mollerup","year":"2001","unstructured":"Mollerup J, Jorgensen ST, Hougaard C, Hoffmann EK (2001) Identification of a murine cysteinyl leukotriene receptor by expression in Xenopus laevis oocytes. Biochim Biophys Acta 1517(3):455\u2013459","journal-title":"Biochim Biophys Acta"},{"issue":"50","key":"72_CR24","doi-asserted-by":"crossref","first-page":"47489","DOI":"10.1074\/jbc.M107556200","volume":"276","author":"YQ Hui","year":"2001","unstructured":"Hui YQ, Yang GC, Galczenski H, Figueroa DJ, Austin CP, Copeland NG et al (2001) The murine cysteinyl leukotriene 2 (CysLT(2)) receptor \u2013 cDNA and genomic cloning, alternative splicing, and in vitro characterization. J Biol Chem 276(50):47489\u201347495","journal-title":"J Biol Chem"},{"issue":"14","key":"72_CR25","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1073\/pnas.141221498","volume":"98","author":"EA Mellor","year":"2001","unstructured":"Mellor EA, Maekawa A, Austen KF, Boyce JA (2001) Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells. Proc Natl Acad Sci U S A 98(14):7964\u20137969","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6738","key":"72_CR26","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","volume":"399","author":"KR Lynch","year":"1999","unstructured":"Lynch KR, O\u2019Neill GP, Liu Q, Im DS, Sawyer N, Metters KM et al (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399(6738):789\u2013793","journal-title":"Nature"},{"issue":"39","key":"72_CR27","doi-asserted-by":"crossref","first-page":"30531","DOI":"10.1074\/jbc.M003490200","volume":"275","author":"CE Heise","year":"2000","unstructured":"Heise CE, O\u2019Dowd BF, Figueroa DJ, Sawyer N, Nguyen T, Im DS et al (2000) Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem 275(39):30531\u201330536","journal-title":"J Biol Chem"},{"issue":"20","key":"72_CR28","doi-asserted-by":"crossref","first-page":"11589","DOI":"10.1073\/pnas.2034927100","volume":"100","author":"EA Mellor","year":"2003","unstructured":"Mellor EA, Frank N, Soler D, Hodge MR, Lora JM, Austen KF et al (2003) Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: functional distinction from CysLT1R. Proc Natl Acad Sci U S A 100(20):11589\u201311593","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"72_CR29","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1182\/blood-2007-07-100453","volume":"110","author":"Y Jiang","year":"2007","unstructured":"Jiang Y, Borrelli LA, Kanaoka Y, Bacskai BJ, Boyce JA (2007) CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 110(9):3263\u20133270","journal-title":"Blood"},{"key":"72_CR30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1100\/tsw.2007.197","volume":"7","author":"R Franco","year":"2007","unstructured":"Franco R, Casado V, Cortes A, Ferrada C, Mallol J, Woods A et al (2007) Basic concepts in G-protein-coupled receptor homo- and heterodimerization. ScientificWorldJournal 7:48\u201357","journal-title":"ScientificWorldJournal"},{"issue":"3","key":"72_CR31","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1378\/chest.121.3.732","volume":"121","author":"K Minoguchi","year":"2002","unstructured":"Minoguchi K, Kohno Y, Minoguchi H, Kihara N, Sano Y, Yasuhara H et al (2002) Reduction of eosinophilic inflammation in the airways of patients with asthma using montelukast. Chest 121(3):732\u2013738","journal-title":"Chest"},{"issue":"8749","key":"72_CR32","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/0140-6736(91)91709-4","volume":"337","author":"KP Hui","year":"1991","unstructured":"Hui KP, Barnes NC (1991) Lung function improvement in asthma with a cysteinyl-leukotriene receptor antagonist. Lancet 337(8749):1062\u20131063","journal-title":"Lancet"},{"issue":"8","key":"72_CR33","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1365-2745.2002.01440.x","volume":"32","author":"Y Tohda","year":"2002","unstructured":"Tohda Y, Fujimura M, Taniguchi H, Takagi K, Igarashi T, Yasuhara H et al (2002) Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients. Clin Exp Allergy 32(8):1180\u20131186","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"72_CR34","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/ajrccm.155.4.9105060","volume":"155","author":"J Tamaoki","year":"1997","unstructured":"Tamaoki J, Kondo M, Sakai N, Nakata J, Takemura H, Nagai A et al (1997) Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi-Idai Asthma Research Group. Am J Respir Crit Care Med 155(4):1235\u20131240","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"72_CR35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM199901213400306","volume":"340","author":"JM Drazen","year":"1999","unstructured":"Drazen JM, Israel E, O\u2019Byrne PM (1999) Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340(3):197\u2013206","journal-title":"N Engl J Med"},{"issue":"11","key":"72_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/archinte.158.11.1213","volume":"158","author":"TF Reiss","year":"1998","unstructured":"Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB (1998) Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med 158(11):1213\u20131220","journal-title":"Arch Intern Med"},{"issue":"2","key":"72_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-132-2-200001180-00002","volume":"132","author":"JM Edelman","year":"2000","unstructured":"Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF et al (2000) Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group. Ann Intern Med 132(2):97\u2013104","journal-title":"Ann Intern Med"},{"issue":"3","key":"72_CR38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199807163390302","volume":"339","author":"JA Leff","year":"1998","unstructured":"Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L et al (1998) Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N Engl J Med 339(3):147\u2013152","journal-title":"N Engl J Med"},{"issue":"20","key":"72_CR39","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1056\/NEJMoa070013","volume":"356","author":"SP Peters","year":"2007","unstructured":"Peters SP, Anthonisen N, Castro M, Holbrook JT, Irvin CG, Smith LJ et al (2007) Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 356(20):2027\u20132039","journal-title":"N Engl J Med"},{"issue":"6","key":"72_CR40","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/0003-4819-130-6-199903160-00005","volume":"130","author":"K Malmstrom","year":"1999","unstructured":"Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX et al (1999) Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast\/Beclomethasone Study Group. Ann Intern Med 130(6):487\u2013495","journal-title":"Ann Intern Med"},{"key":"72_CR41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1440-1592.2000.00160.x","volume":"49","author":"K Wada","year":"2000","unstructured":"Wada K, Minoguchi K, Adachi M (2000) Effect of a leukotriene receptor antagonist, pranlukast hydrate, on airway inflammation and airway hyper responsiveness in patients with moderate to severe asthma. Allergol Int 49:63\u201368","journal-title":"Allergol Int"},{"issue":"3","key":"72_CR42","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1136\/thorax.58.3.211","volume":"58","author":"DB Price","year":"2003","unstructured":"Price DB, Hernandez D, Magyar P, Fiterman J, Beeh KM, James IG et al (2003) Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 58(3):211\u2013216","journal-title":"Thorax"},{"issue":"6","key":"72_CR43","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1164\/ajrccm.160.6.9803042","volume":"160","author":"M Laviolette","year":"1999","unstructured":"Laviolette M, Malmstrom K, Lu S, Chervinsky P, Pujet JC, Peszek I et al (1999) Montelukast added to inhaled beclomethasone in treatment of asthma. Montelukast\/Beclomethasone Additivity Group. Am J Respir Crit Care Med 160(6):1862\u20131868","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"72_CR44","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","volume":"364","author":"D Price","year":"2011","unstructured":"Price D, Musgrave SD, Shepstone L, Hillyer EV, Sims EJ, Gilbert RFT et al (2011) Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 364(18):1695\u20131707","journal-title":"N Engl J Med"},{"issue":"4 Pt 1","key":"72_CR45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1164\/ajrccm.149.4.8143061","volume":"149","author":"R Dworski","year":"1994","unstructured":"Dworski R, Fitzgerald GA, Oates JA, Sheller JR (1994) Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 149(4 Pt 1):953\u2013959","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Pt 1","key":"72_CR46","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/ajrccm\/147.6_Pt_1.1472","volume":"147","author":"KM O\u2019Shaughnessy","year":"1993","unstructured":"O\u2019Shaughnessy KM, Wellings R, Gillies B, Fuller RW (1993) Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis 147(6 Pt 1):1472\u20131476","journal-title":"Am Rev Respir Dis"},{"issue":"7420","key":"72_CR47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.327.7420.891","volume":"327","author":"L Bjermer","year":"2003","unstructured":"Bjermer L, Bisgaard H, Bousquet J, Fabbri LM, Greening AP, Haahtela T et al (2003) Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial. BMJ 327(7420):891","journal-title":"BMJ"},{"issue":"6","key":"72_CR48","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1081-1206(10)61430-5","volume":"92","author":"J Ilowite","year":"2004","unstructured":"Ilowite J, Webb R, Friedman B, Kerwin E, Bird SR, Hustad CM et al (2004) Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol 92(6):641\u2013648","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"72_CR49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/thorax.55.4.260","volume":"55","author":"RJ Dockhorn","year":"2000","unstructured":"Dockhorn RJ, Baumgartner RA, Leff JA, Noonan M, Vandormael K, Stricker W et al (2000) Comparison of the effects of intravenous and oral montelukast on airway function: a double blind, placebo controlled, three period, crossover study in asthmatic patients. Thorax 55(4):260\u2013265","journal-title":"Thorax"},{"issue":"2","key":"72_CR50","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jaci.2009.11.015","volume":"125","author":"CA Camargo Jr","year":"2010","unstructured":"Camargo CA Jr, Gurner DM, Smithline HA, Chapela R, Fabbri LM, Green SA et al (2010) A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 125(2):374\u2013380","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"72_CR51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1398-9995.2006.01007.x","volume":"61","author":"DB Price","year":"2006","unstructured":"Price DB, Swern A, Tozzi CA, Philip G, Polos P (2006) Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 61(6):737\u2013742","journal-title":"Allergy"},{"issue":"1","key":"72_CR52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","volume":"165","author":"SE Dahlen","year":"2002","unstructured":"Dahlen SE, Malmstrom K, Nizankowska E, Dahlen B, Kuna P, Kowalski M et al (2002) Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 165(1):9\u201314","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"72_CR53","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thx.2007.093971","volume":"63","author":"R Beasley","year":"2008","unstructured":"Beasley R, Bibby S, Weatherall M (2008) Leukotriene receptor antagonist therapy and Churg-Strauss syndrome: culprit or innocent bystander? Thorax 63(10):847\u2013849","journal-title":"Thorax"},{"issue":"10","key":"72_CR54","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1136\/thx.2007.093955","volume":"63","author":"N Nathani","year":"2008","unstructured":"Nathani N, Little MA, Kunst H, Wilson D, Thickett DR (2008) Churg-Strauss syndrome and leukotriene antagonist use: a respiratory perspective. Thorax 63(10):883\u2013888","journal-title":"Thorax"},{"issue":"5","key":"72_CR55","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1124\/dmd.110.037689","volume":"39","author":"AM Filppula","year":"2011","unstructured":"Filppula AM, Laitila J, Neuvonen PJ, Backman JT (2011) Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations. Drug Metab Dispos 39(5):904\u2013911","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"72_CR56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2125.2011.04086.x","volume":"73","author":"T Karonen","year":"2012","unstructured":"Karonen T, Neuvonen PJ, Backman JT (2012) CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast. Br J Clin Pharmacol 73(2):257\u2013267","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"72_CR57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1517\/14740330902932688","volume":"8","author":"P Manalai","year":"2009","unstructured":"Manalai P, Woo JM, Postolache TT (2009) Suicidality and montelukast. Expert Opin Drug Saf 8(3):273\u2013282","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"72_CR58","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jaci.2012.04.035","volume":"130","author":"GT Schumock","year":"2012","unstructured":"Schumock GT, Stayner LT, Valuck RJ, Joo MJ, Gibbons RD, Lee TA (2012) Risk of suicide attempt in asthmatic children and young adults prescribed leukotriene-modifying agents: a nested case\u2013control study. J Allergy Clin Immunol 130(2):368\u2013375","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"72_CR59","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaci.2009.08.010","volume":"124","author":"G Philip","year":"2009","unstructured":"Philip G, Hustad C, Noonan G, Malice MP, Ezekowitz A, Reiss TF et al (2009) Reports of suicidality in clinical trials of montelukast. J Allergy Clin Immunol 124(4):691\u2013696, e6","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"72_CR60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1378\/chest.116.1.65","volume":"116","author":"C Furukawa","year":"1999","unstructured":"Furukawa C, Atkinson D, Forster TJ, Nazzario K, Simpson B, Uryniak T et al (1999) Controlled trial of two formulations of cromolyn sodium in the treatment of asthmatic patients\u2009>\u2009or\u2009=\u200912 years of age. Intal Study Group. Chest 116(1):65\u201372","journal-title":"Chest"},{"issue":"4","key":"72_CR61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s11325-011-0639-1","volume":"16","author":"NC Netzer","year":"2012","unstructured":"Netzer NC, Kupper T, Voss HW, Eliasson AH (2012) The actual role of sodium cromoglycate in the treatment of asthma\u2014a critical review. Sleep Breath 16(4):1027\u20131032","journal-title":"Sleep Breath"},{"issue":"10","key":"72_CR62","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/thx.43.10.756","volume":"43","author":"KB Leung","year":"1988","unstructured":"Leung KB, Flint KC, Brostoff J, Hudspith BN, Johnson NM, Lau HY et al (1988) Effects of sodium cromoglycate and nedocromil sodium on histamine secretion from human lung mast cells. Thorax 43(10):756\u2013761","journal-title":"Thorax"},{"issue":"1","key":"72_CR63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0091-6749(87)80183-5","volume":"80","author":"AB Kay","year":"1987","unstructured":"Kay AB, Walsh GM, Moqbel R, MacDonald AJ, Nagakura T, Carroll MP et al (1987) Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol 80(1):1\u20138","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"72_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314164","volume":"86","author":"Y Yang","year":"2010","unstructured":"Yang Y, Lu JY, Wu X, Summer S, Whoriskey J, Saris C et al (2010) G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology 86(1):1\u20135","journal-title":"Pharmacology"},{"issue":"4","key":"72_CR65","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1183\/09031936.97.10040858","volume":"10","author":"M Hoshino","year":"1997","unstructured":"Hoshino M, Nakamura Y (1997) The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics. Eur Respir J 10(4):858\u2013865","journal-title":"Eur Respir J"},{"issue":"7","key":"72_CR66","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0954-6111(98)90194-9","volume":"92","author":"M Hoshino","year":"1998","unstructured":"Hoshino M, Nakamura Y, Sim JJ, Tomioka H (1998) A comparative study of the effects of ketotifen, disodium cromoglycate, and beclomethasone dipropionate on bronchial mucosa and asthma symptoms in patients with atopic asthma. Respir Med 92(7):942\u2013950","journal-title":"Respir Med"},{"issue":"1","key":"72_CR67","first-page":"53","volume":"66","author":"JE Hoag","year":"1991","unstructured":"Hoag JE, McFadden ER Jr (1991) Long-term effect of cromolyn sodium on nonspecific bronchial hyperresponsiveness: a review. Ann Allergy 66(1):53\u201363","journal-title":"Ann Allergy"},{"issue":"11","key":"72_CR68","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/thorax.55.11.913","volume":"55","author":"MJA Tasche","year":"2000","unstructured":"Tasche MJA, Uijen JHJM, Bernsen RMD, de Jongste JC, van der Wouden JC (2000) Inhaled disodium cromoglycate (DSCG) as maintenance therapy in children with asthma: a systematic review. Thorax 55(11):913\u2013920","journal-title":"Thorax"},{"key":"72_CR69","doi-asserted-by":"crossref","unstructured":"Warner JO (1989) The place of Intal in paediatric practice. Respir Med 83 Suppl A:33\u201337","DOI":"10.1016\/S0954-6111(89)80248-3"},{"issue":"5","key":"72_CR70","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0954-6111(95)90009-8","volume":"89","author":"JF Price","year":"1995","unstructured":"Price JF, Weller PH (1995) Comparison of fluticasone propionate and sodium cromoglycate for the treatment of childhood asthma (an open parallel group study). Respir Med 89(5):363\u2013368","journal-title":"Respir Med"},{"issue":"7006","key":"72_CR71","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/bmj.311.7006.663","volume":"311","author":"JO Warner","year":"1995","unstructured":"Warner JO (1995) Review of prescribed treatment for children with asthma in 1990. BMJ 311(7006):663\u2013666","journal-title":"BMJ"},{"issue":"5","key":"72_CR72","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1164\/ajrccm\/137.5.1002","volume":"137","author":"SE Wenzel","year":"1988","unstructured":"Wenzel SE, Fowler AA 3rd, Schwartz LB (1988) Activation of pulmonary mast cells by bronchoalveolar allergen challenge. In vivo release of histamine and tryptase in atopic subjects with and without asthma. Am Rev Respir Dis 137(5):1002\u20131008","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"72_CR73","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/137.1.62","volume":"137","author":"AJ Wardlaw","year":"1988","unstructured":"Wardlaw AJ, Dunnette S, Gleich GJ, Collins JV, Kay AB (1988) Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 137(1):62\u201369","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"72_CR74","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1164\/ajrccm\/142.1.126","volume":"142","author":"MC Liu","year":"1990","unstructured":"Liu MC, Bleecker ER, Lichtenstein LM, Kagey-Sobotka A, Niv Y, McLemore TL et al (1990) Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. Am Rev Respir Dis 142(1):126\u2013132","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"72_CR75","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1164\/ajrccm\/144.1.83","volume":"144","author":"NN Jarjour","year":"1991","unstructured":"Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW (1991) Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction. Am Rev Respir Dis 144(1):83\u201387","journal-title":"Am Rev Respir Dis"},{"issue":"4","key":"72_CR76","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1172\/JCI112937","volume":"79","author":"TB Casale","year":"1987","unstructured":"Casale TB, Wood D, Richerson HB, Trapp S, Metzger WJ, Zavala D et al (1987) Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with methacholine bronchial hyperresponsiveness. J Clin Invest 79(4):1197\u20131203","journal-title":"J Clin Invest"},{"issue":"4","key":"72_CR77","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0091-6749(91)90158-K","volume":"88","author":"DH Broide","year":"1991","unstructured":"Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwartz LB et al (1991) Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 88(4):637\u2013648","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"72_CR78","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd2465","volume":"7","author":"RL Thurmond","year":"2008","unstructured":"Thurmond RL, Gelfand EW, Dunford PJ (2008) The role of histamine H1 and H4 receptors in allergic inflammation: the search for new antihistamines. Nat Rev Drug Discov 7(1):41\u201353","journal-title":"Nat Rev Drug Discov"},{"key":"72_CR79","first-page":"27","volume":"17","author":"RA Bakker","year":"2002","unstructured":"Bakker RA, Timmerman H, Leurs R (2002) Histamine receptors: specific ligands, receptor biochemistry, and signal transduction. Clin Allergy Immunol 17:27\u201364","journal-title":"Clin Allergy Immunol"},{"key":"72_CR80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1046\/j.1365-2222.1999.0290s3098.x","volume":"29","author":"FER Simons","year":"1999","unstructured":"Simons FER (1999) Is antihistamine (H-1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy 29:98\u2013104","journal-title":"Clin Exp Allergy"},{"key":"72_CR81","first-page":"221","volume":"17","author":"JL Lordan","year":"2002","unstructured":"Lordan JL, Holgate ST (2002) H1-antihistamines in asthma. Clin Allergy Immunol 17:221\u2013248","journal-title":"Clin Allergy Immunol"},{"issue":"2","key":"72_CR82","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/ajrccm\/136.2.369","volume":"136","author":"P Rafferty","year":"1987","unstructured":"Rafferty P, Beasley R, Holgate ST (1987) The contribution of histamine to immediate bronchoconstriction provoked by inhaled allergen and adenosine 5\u2032 monophosphate in atopic asthma. Am Rev Respir Dis 136(2):369\u2013373","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"72_CR83","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1164\/ajrccm.155.6.9196086","volume":"155","author":"A Roquet","year":"1997","unstructured":"Roquet A, Dahlen B, Kumlin M, Ihre E, Anstren G, Binks S et al (1997) Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 155(6):1856\u20131863","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"72_CR84","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2332\/allergolint.14-RAI-0766","volume":"63","author":"K Ohta","year":"2014","unstructured":"Ohta K, Ichinose M, Nagase H, Yamaguchi M, Sugiura H, Tohda Y et al (2014) Japanese Guideline for Adult Asthma 2014. Allergol Int 63(3):293\u2013333","journal-title":"Allergol Int"},{"key":"72_CR85","unstructured":"Global Initiative for Asthma (GINA) (2014) The global strategy for asthma management and prevention. http:\/\/www.ginasthma.org\/"},{"key":"72_CR86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2005.12.058","volume":"533","author":"S Rolin","year":"2006","unstructured":"Rolin S, Masereel B, Dogn\u00e9 J (2006) Prostanoids as pharmacological targets in COPD and asthma. Eur J Pharmacol 533:89\u2013100","journal-title":"Eur J Pharmacol"},{"issue":"2\u20133","key":"72_CR87","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0929-7855(95)00031-K","volume":"12","author":"T Tanabe","year":"1995","unstructured":"Tanabe T, Ullrich V (1995) Prostacyclin and thromboxane synthases. J Lipid Mediat Cell Signal 12(2\u20133):243\u2013255","journal-title":"J Lipid Mediat Cell Signal"},{"issue":"1","key":"72_CR88","first-page":"53","volume":"3","author":"R Nusing","year":"1990","unstructured":"Nusing R, Lesch R, Ullrich V (1990) Immunohistochemical localization of thromboxane synthase in human tissues. Eicosanoids 3(1):53\u201358","journal-title":"Eicosanoids"},{"issue":"6310","key":"72_CR89","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/349617a0","volume":"349","author":"M Hirata","year":"1991","unstructured":"Hirata M, Hayashi Y, Ushikubi F, Yokota Y, Kageyama R, Nakanishi S et al (1991) Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 349(6310):617\u2013620","journal-title":"Nature"},{"key":"72_CR90","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cellsig.2003.10.008","volume":"16","author":"J Huang","year":"2004","unstructured":"Huang J, Ramamurthy S, Lin X, Le Breton G (2004) Cell signalling through thromboxane A2 receptors. Cell Signal 16:521\u2013533","journal-title":"Cell Signal"},{"issue":"14","key":"72_CR91","doi-asserted-by":"crossref","first-page":"9309","DOI":"10.1016\/S0021-9258(18)31586-2","volume":"266","author":"A Shenker","year":"1991","unstructured":"Shenker A, Goldsmith P, Unson CG, Spiegel AM (1991) The G protein coupled to the thromboxane A2 receptor in human platelets is a member of the novel Gq family. J Biol Chem 266(14):9309\u20139313","journal-title":"J Biol Chem"},{"issue":"1","key":"72_CR92","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0022-3565(25)38141-3","volume":"265","author":"GW Dorn 2nd","year":"1993","unstructured":"Dorn GW 2nd, Becker MW (1993) Thromboxane A2 stimulated signal transduction in vascular smooth muscle. J Pharmacol Exp Ther 265(1):447\u2013456","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"72_CR93","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI118518","volume":"97","author":"T Hirata","year":"1996","unstructured":"Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S (1996) Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 97(4):949\u2013956","journal-title":"J Clin Invest"},{"issue":"6 Pt 1","key":"72_CR94","first-page":"L361","volume":"257","author":"JH Widdicombe","year":"1989","unstructured":"Widdicombe JH, Ueki IF, Emery D, Margolskee D, Yergey J, Nadel JA (1989) Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. Am J Physiol 257(6 Pt 1):L361\u2013L365","journal-title":"Am J Physiol"},{"issue":"4","key":"72_CR95","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1476-5381.1983.tb10530.x","volume":"79","author":"GA Higgs","year":"1983","unstructured":"Higgs GA, Moncada S, Salmon JA, Seager K (1983) The source of thromboxane and prostaglandins in experimental inflammation. Br J Pharmacol 79(4):863\u2013868","journal-title":"Br J Pharmacol"},{"issue":"8","key":"72_CR96","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1073\/pnas.72.8.2994","volume":"72","author":"M Hamberg","year":"1975","unstructured":"Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 72(8):2994\u20132998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"72_CR97","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/0149-2918(95)80002-6","volume":"17","author":"M Kurosawa","year":"1995","unstructured":"Kurosawa M (1995) Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma. Clin Ther 17(1):2\u201311, discussion 1","journal-title":"Clin Ther"},{"issue":"1","key":"72_CR98","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1378\/chest.118.1.73","volume":"118","author":"J Tamaoki","year":"2000","unstructured":"Tamaoki J, Kondo M, Nakata J, Nagano Y, Isono K, Nagai A (2000a) Effect of a thromboxane A(2) antagonist on sputum production and its physicochemical properties in patients with mild to moderate asthma. Chest 118(1):73\u201379","journal-title":"Chest"},{"key":"72_CR99","first-page":"1759","volume":"8","author":"HG Morris","year":"1980","unstructured":"Morris HG, Sherman NA, Shepperdson FT, Selner JC (1980) Radioimmunoassay of thromboxane B2 in plasma of normal and asthmatic subjects. Adv Prostaglandin Thromboxane Res 8:1759\u20131764","journal-title":"Adv Prostaglandin Thromboxane Res"},{"issue":"1","key":"72_CR100","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1472-8206.1997.tb00163.x","volume":"11","author":"P Devillier","year":"1997","unstructured":"Devillier P, Bessard G (1997) Thromboxane A2 and related prostaglandins in airways. Fundam Clin Pharmacol 11(1):2\u201318","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"72_CR101","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/0091-6749(91)90013-E","volume":"87","author":"SE Wenzel","year":"1991","unstructured":"Wenzel SE, Westcott JY, Larsen GL (1991) Bronchoalveolar lavage fluid mediator levels 5 minutes after allergen challenge in atopic subjects with asthma: relationship to the development of late asthmatic responses. J Allergy Clin Immunol 87(2):540\u2013548","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"72_CR102","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","volume":"146","author":"M Kumlin","year":"1992","unstructured":"Kumlin M, Dahlen B, Bjorck T, Zetterstrom O, Granstrom E, Dahlen SE (1992) Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 146(1):96\u2013103","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"72_CR103","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0091-6749(95)70011-0","volume":"96","author":"Y Oosterhoff","year":"1995","unstructured":"Oosterhoff Y, Kauffman HF, Rutgers B, Zijlstra FJ, Koeter GH, Postma DS (1995) Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing. J Allergy Clin Immunol 96(2):219\u2013229","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"72_CR104","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/ajrccm\/139.2.450","volume":"139","author":"SE Wenzel","year":"1989","unstructured":"Wenzel SE, Westcott JY, Smith HR, Larsen GL (1989) Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 139(2):450\u2013457","journal-title":"Am Rev Respir Dis"},{"issue":"2\u20133","key":"72_CR105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0014-2999(03)02014-4","volume":"474","author":"V Capra","year":"2003","unstructured":"Capra V, Habib A, Accomazzo MR, Ravasi S, Citro S, Levy-Toledano S et al (2003) Thromboxane prostanoid receptor in human airway smooth muscle cells: a relevant role in proliferation. Eur J Pharmacol 474(2\u20133):149\u2013159","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"72_CR106","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1034\/j.1399-3003.2000.01523.x","volume":"15","author":"IP Hall","year":"2000","unstructured":"Hall IP (2000) Second messengers, ion channels and pharmacology of airway smooth muscle. Eur Respir J 15(6):1120\u20131127","journal-title":"Eur Respir J"},{"issue":"3 Suppl","key":"72_CR107","doi-asserted-by":"crossref","first-page":"417S","DOI":"10.1378\/chest.123.3_suppl.417S","volume":"123","author":"AM Vignola","year":"2003","unstructured":"Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V et al (2003) Airway remodeling in asthma. Chest 123(3 Suppl):417S\u2013422S","journal-title":"Chest"},{"key":"#cr-split#-72_CR108.1","unstructured":"Xiang A, Uchida Y, Nomura A, Iijima H, Sakamoto T, Ishii Y et al (2002) Involvement of thromboxane A"},{"key":"#cr-split#-72_CR108.2","unstructured":"(2) in airway mucous cells in asthma-related cough. J Appl Physiol (1985) 92(2):763-770"},{"issue":"6","key":"72_CR109","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0091-6749(99)70179-X","volume":"103","author":"M Hoshino","year":"1999","unstructured":"Hoshino M, Sim J, Shimizu K, Nakayama H, Koya A (1999) Effect of AA-2414, a thromboxane A2 receptor antagonist, on airway inflammation in subjects with asthma. J Allergy Clin Immunol 103(6):1054\u20131061","journal-title":"J Allergy Clin Immunol"},{"issue":"1 Pt 1","key":"72_CR110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0091-6749(91)90208-6","volume":"87","author":"M Fujimura","year":"1991","unstructured":"Fujimura M, Sakamoto S, Saito M, Miyake Y, Matsuda T (1991) Effect of a thromboxane A2 receptor antagonist (AA-2414) on bronchial hyperresponsiveness to methacholine in subjects with asthma. J Allergy Clin Immunol 87(1 Pt 1):23\u201327","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"72_CR111","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/thx.41.12.955","volume":"41","author":"M Fujimura","year":"1986","unstructured":"Fujimura M, Sasaki F, Nakatsumi Y, Takahashi Y, Hifumi S, Taga K et al (1986) Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects. Thorax 41(12):955\u2013959","journal-title":"Thorax"},{"issue":"2","key":"72_CR112","doi-asserted-by":"crossref","first-page":"S461","DOI":"10.1016\/j.jaci.2005.09.001","volume":"117","author":"DB Corry","year":"2006","unstructured":"Corry DB, Kheradmand F (2006) Control of allergic airway inflammation through immunomodulation. J Allergy Clin Immunol 117(2):S461\u2013S464","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"72_CR113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1081\/JAS-100000041","volume":"38","author":"T Horiguchi","year":"2001","unstructured":"Horiguchi T, Tachikawa S, Handa M, Hanazono K, Kondo R, Ishibashi A et al (2001) Effects of suplatast tosilate on airway inflammation and airway hyperresponsiveness. J Asthma 38(4):331\u2013336","journal-title":"J Asthma"},{"issue":"19","key":"72_CR114","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0024-3205(95)00132-P","volume":"56","author":"H Yamaya","year":"1995","unstructured":"Yamaya H, Basaki Y, Togawa M, Kojima M, Kiniwa M, Matsuura N (1995) Down-regulation of Th2 cell-mediated murine peritoneal eosinophilia by antiallergic agents. Life Sci 56(19):1647\u20131654","journal-title":"Life Sci"},{"issue":"8","key":"72_CR115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0024-3205(99)00303-3","volume":"65","author":"N Oda","year":"1999","unstructured":"Oda N, Minoguchi K, Yokoe T, Hashimoto T, Wada K, Miyamoto M et al (1999) Effect of suplatast tosilate (IPD-1151T) on cytokine production by allergen-specific human Th1 and Th2 cell lines. Life Sci 65(8):763\u2013770","journal-title":"Life Sci"},{"issue":"6","key":"72_CR116","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1081\/JAS-120004925","volume":"39","author":"M Yoshida","year":"2002","unstructured":"Yoshida M, Aizawa H, Inoue H, Matsumoto K, Koto H, Komori M et al (2002) Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients. J Asthma 39(6):545\u2013552","journal-title":"J Asthma"},{"issue":"5","key":"72_CR117","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1067\/mai.2003.1415","volume":"111","author":"Y Sano","year":"2003","unstructured":"Sano Y, Suzuki N, Yamada H, To Y, Ogawa C, Ohta K et al (2003) Effects of suplatast tosilate on allergic eosinophilic airway inflammation in patients with mild asthma. J Allergy Clin Immunol 111(5):958\u2013966","journal-title":"J Allergy Clin Immunol"},{"issue":"9226","key":"72_CR118","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)02501-0","volume":"356","author":"J Tamaoki","year":"2000","unstructured":"Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J et al (2000b) Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double-blind randomised study. Lancet 356(9226):273\u2013278","journal-title":"Lancet"}],"container-title":["Handbook of Experimental Pharmacology","Pharmacology and Therapeutics of Asthma and COPD"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2016_72","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:03:01Z","timestamp":1749700981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/164_2016_72"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9783319521732","9783319521756"],"references-count":119,"URL":"https:\/\/doi.org\/10.1007\/164_2016_72","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"9 November 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}